Expression of folate receptor alpha and CA125 and its clinical significance in endometrial carcinoma
10.3969/j.issn.1006-5725.2017.04.025
- VernacularTitle:子宫内膜腺癌组织FRA和CA125的表达及意义
- Author:
Jinyan LI
;
Xiaodan JI
;
Youming WU
;
Meiling LI
;
Yinghui LIU
;
Shuming HE
- Keywords:
Endometrial carcinoma;
Endometrial hyperplasia;
Folate receptor alpha;
CA125;
Clinicopathological characteristics
- From:
The Journal of Practical Medicine
2017;33(4):594-598
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the expression and the pathomechanism of folate receptor alpha(FRα) and CA125 in the development and progression of endometrial carcinoma.Methods Sixty samples of endometrial carcinoma tissues,46 samples of endometrial hyperplasia tissues and 10 normal endometrial tissues were collected in the study.Immunohistochemical methods were used to detect the expression of Frαand CA125 in all tissues.The expressions of FRα and CA125 and their correlation with clinicopathological characteristics were analyzed.Results FRα was positively expressed in 93.9％ of the endometrial carcinoma tissues,with a strongly positive rate of 65.0％,which was significantly higher than that in endometrial hyperplasia tissues and normal endometrial tissues (P ＜ 0.05).The highly expressed FRαin endometrial carcinoma tissues was associated with age,FIGO stage and histologic types (P ＜ 0.05),while no statistical significance was found between the high expression of FRαand myometrial invasion.The expression of FRα in endometrial atypical hyperplasia was higher than that in other hyperplasia subgroups.The expression of CA125 in endometrial carcinoma tissues and endometrial hyperplasia tissues were both higher than that in normal endometrial tissues (P ＜ 0.05).Conclusion FRα may play an important role in the carcinogenesis and progression of endometrial carcinoma,and act as a target of therapy and a kind of assessment for prognosis in endometrial carcinoma.CA125 may be involved in the development of endometrial lesions and further researches are needed to confirm a physiological mechanism between FRA and CA125 in carcinogenesis of endometrial carcinoma.
